Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.
about
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Nicotine receptor partial agonists for smoking cessationAntidepressants for smoking cessationInterventions for preventing weight gain after smoking cessationNicotine receptor partial agonists for smoking cessationAntidepressants for smoking cessationAntidepressants for smoking cessationEffect of varying levels of disease management on smoking cessation: a randomized trialCardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysisDesign and baseline characteristics from the KAN-QUIT disease management intervention for rural smokers in primary care.Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose.The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study.Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic reviewRetreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trialVarenicline: A review of the literature and place in therapy.Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.How does bupropion work as a smoking cessation aid?A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.The use of bupropion SR in cigarette smoking cessationAn observational study of the Korean proactive quitline service for smoking cessation and relapse preventionBupropion SR for smoking cessation.Effectiveness of smoking cessation interventions: review of evidence and implications for best practice in Australian health care settings.A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service reportPharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications.Bupropion and nicotine patch as smoking cessation aids in alcoholics.Bupropion and cognitive-behavioral treatment for depression in smoking cessationTobacco addiction.Bupropion for the treatment of nicotine withdrawal and craving.Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individualsEvidence for smoking cessation: Implications for gender-specific strategies.Cost effectiveness analysis of smoking cessation interventions.Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort studyComparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinenceWhich is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?Therapy for Cessation of Smoking.Pharmacotherapy for smoking cessation.Treating tobacco dependence in a medical setting.Effectiveness of Switching Smoking-Cessation Medications Following Relapse.Validating Use of Internet-Submitted Carbon Monoxide Values by Video to Determine Quit Status.
P2860
Q21093272-AFF675E1-4FF2-4000-88F6-3E1924B1D633Q24200322-200B68F1-BC19-4DEA-83B6-1ECB2D596B3AQ24201167-11A2143B-B30A-4184-8515-F5FCDA8D46B3Q24203883-ED797F8D-6A9B-4593-BCF0-D0727900C47BQ24235456-BB184120-02FF-45EA-954A-2166AC191002Q24245969-FC2D7804-B6A5-4498-B6D9-84B2E18F47CEQ24246426-A0425CC0-E7D2-43D6-A9ED-CF121E520E16Q24645158-597A4EB0-A826-407B-87D8-8ED470B7B9ADQ28303682-7E5AF1C4-8FD0-4030-A3E7-27FEC54EED4AQ30484434-320A5A23-DDF5-496E-9D06-BEDF1A68D3BFQ33351611-810A6938-9370-49BD-B3C6-02B72285BA0CQ33616676-BDB4A187-38EA-4467-B27A-36689BABA124Q33677642-5C51E7F7-A130-4A9C-8F9B-59A739CF39E0Q33945774-72C0B044-EFFE-4C2B-825E-07F635A3F8DAQ34116684-F2BD096A-F7DB-4C37-8C75-4A92791008ECQ34136381-F45E5BA0-24CC-4595-B017-16E1040FB14BQ34350152-3A112E8A-0602-4666-B467-FDC578E13FE4Q34444129-EC844F80-572B-4C5E-B580-73766B0BA777Q34535460-9934E375-8008-4071-9864-007BBF13956AQ34779470-A09D99C0-913E-4FBC-B221-4CADB1DD3BD7Q35045776-3B48F55E-0BFE-4D52-90F1-13DB6D2A41FBQ35095215-39EB894D-E70E-4675-B617-AF875F8450B4Q35620288-F93876E8-723B-4307-AAE2-FEE31C0C401DQ35737760-169A71FD-64B9-4499-92D5-2EC4651D35DEQ36052831-7E8F6CF8-0B96-4CE8-AD47-CFF1B38EA435Q36119841-46240043-D21B-4688-A170-68EDAEE859D1Q36404616-6F7AC91E-1F59-4F03-8774-B3E46DC471F8Q36519493-457910BF-DA38-49D8-A152-6EDF1C893686Q36532139-D150552D-53A4-4F6E-829A-08BBEB77AC65Q36594551-1C37EDAD-9F33-48A3-AD33-7655737F6312Q36623294-6E4F993F-FCA9-41A6-9545-A4BCDE6D0C1DQ36638298-2F582C04-2E9B-4693-BBBA-DD08AB2CD886Q36854061-025A8D9E-10F3-4FC3-B429-19EBC926EA3CQ36960396-EBF299BC-09F9-4609-9BD9-7BC1780406F2Q37000723-D06EBBB5-9740-4E73-9CB1-4139E5C681ABQ37039312-580865D1-10B4-4396-9144-23346D5DD431Q37362638-30D108D7-DDFB-470D-B00D-5FCB1057CB6BQ37520911-A4B79B9F-3787-4086-92AA-46926BCC7A6CQ38740690-B726CA52-010E-42EA-8470-10C94AB9FDA8Q38785942-42F84FFD-8049-414C-B47B-91A177D846FB
P2860
Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Bupropion SR as an aid to smok ...... ized placebo-controlled study.
@en
type
label
Bupropion SR as an aid to smok ...... ized placebo-controlled study.
@en
prefLabel
Bupropion SR as an aid to smok ...... ized placebo-controlled study.
@en
P2093
P356
P1476
Bupropion SR as an aid to smok ...... mized placebo-controlled study
@en
P2093
B D Jamerson
L A Herrero
R P Kustra
P304
P356
10.1067/MCP.2001.115750
P407
P577
2001-06-01T00:00:00Z